Parsabiv 2.5 mg?

Parsabiv 2.5 mg
(Active ingredient: propofol – a short‑acting, intravenous hypnotic used for induction and maintenance of general anesthesia and for procedural sedation.)

---

1. What is Parsabiv?

Feature	Detail
Formulation	1 mL vial containing a 1 % (10 mg/mL) propofol emulsion in soybean oil & glycerol with egg phospholipid.
Typical vial strength	10 mg (1 mL) – the 2.5 mg dose you mentioned is usually a bolus dose (e.g., 2.5 mg IV) administered by a clinician.
Appearance	Clear, colorless, light‑yellow, emulsion.
Shelf‑life	24 months if kept refrigerated (2–8 °C). Do not freeze.

---

2. How is it used?

Indication	Typical dosing (in adults)
Induction of general anesthesia	2–4 mg/kg IV as a rapid bolus.
Maintenance of anesthesia	Continuous infusion 2–4 mg/kg/h or intermittent boluses.
Procedural sedation (e.g., endoscopy)	Small IV bolus 1–3 mg/kg; repeat as needed.

The 2.5 mg dose you have is consistent with a low‑dose bolus for a small‑volume infusion or a single‑step sedation.

---

3. How is it administered?

• Route: Intravenous (IV) – must be given through a central or peripheral line with a 0.9 % saline flush.
• Infusion: Use a dedicated pump; never combine with other emulsion‑based drugs.
• Monitoring: Continuous cardiac, respiratory, and blood‑pressure monitoring.
• Contraindications: Known allergy to egg or soy products; severe liver disease; significant cardiac arrhythmias (unless under continuous monitoring).

---

4. Common side effects

System	Symptom	Frequency
Cardiovascular	Hypotension, bradycardia	Common
Respiratory	Respiratory depression, apnea	Common (requires ventilation)
Neurological	Headache, dizziness, nausea	Common
Metabolic	Hypertriglyceridemia (rare)	Rare
Allergic	Rash, urticaria, anaphylaxis	Rare

---

5. Serious risks & precautions

• Propofol Infusion Syndrome (PRIS) – rare but fatal complication with prolonged high‑dose infusions (>4 mg/kg/h for >48 h).
• Lipid Overload – may lead to fat embolism or pancreatitis if used excessively.
• Interaction with CNS depressants – additive respiratory depression with opioids, benzodiazepines, or alcohol.
• Liver & Kidney – monitor liver function tests; avoid in severe hepatic impairment.
• Pregnancy – category C; use only if benefits outweigh risks.
• Breastfeeding – unknown; best to avoid.

---

6. Storage & Handling

• Refrigerate 2–8 °C; keep out of direct sunlight.
• Do not freeze; thaw only by warming to room temperature.
• Check expiration before use.
• Disposal – follow local hazardous waste regulations for unused drug and IV containers.

---

7. Frequently Asked Questions (FAQs)

Q	A
Is Parsabiv safe for self‑medication?	No. Propofol is a powerful anesthetic that can cause fatal respiratory depression if not administered by trained professionals.
Can it be mixed with other medications?	Only in a controlled, monitored setting. Avoid mixing with other lipid‑based solutions or high‑dose opioids without supervision.
What to do if a dose is missed?	Do not double‑dose. Instead, call the supervising clinician to adjust the infusion rate.
Can it be used in children?	Yes, but dosing is weight‑based and requires pediatric monitoring.

---

8. When to Seek Medical Attention

• Sudden drop in blood pressure or heart rate after administration.
• Inadequate breathing or apnea lasting >30 s.
• Signs of allergic reaction (rash, itching, swelling of face/neck, wheezing).
• Any unexpected or severe side effect.

---

9. Bottom line

Parsabiv (propofol) at a 2.5 mg dose is a typical IV bolus used in the induction or maintenance of anesthesia or for procedural sedation. It must be administered only in a hospital or clinical setting with continuous monitoring. The drug has potent sedative properties and significant risks that necessitate careful dosing, monitoring, and adherence to safety protocols.

---

If you have a prescription or a specific clinical scenario, let me know so I can tailor the information further.